Exergen Corporation Names Katia Da Silva Almeida Jovino as New Sales Representative for Brazil

December 05, 2024 01:00 AM AEDT | By EIN Presswire
 Exergen Corporation Names Katia Da Silva Almeida Jovino as New Sales Representative for Brazil
Image source: EIN Presswire
WATERTOWN, MA, UNITED STATES, December 4, 2024 /EINPresswire.com/ -- WATERTOWN, Mass. – December 4, 2024 – Exergen Corporation, the leading manufacturer of infrared temperature measurement equipment for medical applications, is proud to announce the appointment of Katia Da Silva Almeida Jovino as Sales Representative for Brazil. In this role she will report directly to Benjamin Kalm and will work closely with Exergen’s distributor network to promote its innovative line of Temporal Artery Thermometers. She will be responsible for driving sales strategies and supporting marketing initiatives aimed at growing Exergen’s market share in Brazil.

Katia Da Silva Almeida Jovino joins Exergen with over 16 years of experience in medical device sales, including hospital equipment, neurovascular products, and sterilization technologies. Most recently, Katia served as Senior Salesperson at Advanced Sterilization Products, a multinational company where she managed key accounts, including Rede D'Or, one of Brazil’s largest hospital networks.

"We are excited to welcome Katia to Exergen," said Dr. Francesco Pompei, CEO of Exergen Corporation. "Her proven ability to build relationships and execute successful strategies will be instrumental in expanding our market share and supporting healthcare professionals with our innovative medical thermometry solutions. Katia's leadership will play a key role in our continued success in Brazil and beyond, making a meaningful impact on patient care and helping to change the way the world takes temperatures.”

Previously she held several roles at leading healthcare companies, including Stryker, Medtronic, and Johnson & Johnson Medical. At Stryker, she was a Therapy Development Specialist for the Neurovascular business unit, supporting sales teams and launching new products across Brazil’s southern and southeastern regions. At Medtronic, Katia drove a 16% compound annual growth rate in sales, a testament to her strategic approach and ability to grow market share.

“The combination of Katia’s nursing and deep experience in sales, product development, and relationship management makes her an invaluable addition to Exergen. Her experience will be instrumental to helping us give medical professionals the medical thermometry they need to improve healthy outcomes for Brazil’s growing population of 216 million," says Benjamin Kalm, Exergen’s Commercial Director for Latin America and the Caribbean.

Katia holds an MBA in Marketing from ESPM, a Master’s degree in Nephrology from the Federal University of São Paulo, and a Bachelor’s degree in Nursing from Universidade Nove de Julho. She is fluent in Portuguese, with intermediate proficiency in English and advanced Spanish, positioning her to effectively engage with a diverse customer base.

About Exergen Corporation
Exergen Corporation, the leader in non-invasive temperature measurement technologies for industrial and medical applications, delivers non-invasive temperature meters with higher accuracy, lower costs, less process control, and higher reliability than previously possible. Known in both healthcare and consumer markets for its award-winning arterial thermometer, Exergen was founded by MIT and Harvard - educated and Harvard researcher Dr. Francesco Pompei, who holds more than 100 patents supporting Exergen products. Exergen Corporation is headquartered in Watertown, Massachusetts, United States.

EXERGEN P/N 850283, Rev 1

Christina Guilbert
email us here
Exergen Corporation

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.